炎症性肠病患者健康膳食自我决策模型构建与支持体系设计

注册号:

Registration number:

ChiCTR2200064943 

最近更新日期:

Date of Last Refreshed on:

2023-05-01 14:08:15 

注册时间:

Date of Registration:

2022-10-24 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

炎症性肠病患者健康膳食自我决策模型构建与支持体系设计

Public title:

Self-decision model of healthy eating and supporting system for patients with inflammatory bowel disease: A study of model construction and empirical research

注册题目简写:

English Acronym:

研究课题的正式科学名称:

炎症性肠病患者健康膳食自我决策模型构建与支持体系设计

Scientific title:

Self-decision model of healthy eating and supporting system for patients with inflammatory bowel disease: A study of model construction and empirical research

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

尹婷婷 

研究负责人:

方健 

Applicant:

Yin Tingting 

Study leader:

Fang Jian 

申请注册联系人电话:

Applicant telephone:

+86 18851835056

研究负责人电话:

Study leader's
telephone:

+86 13776612678

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

yori1998@163.com

研究负责人电子邮件:

Study leader's E-mail:

twj313@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

江苏省南京市栖霞区仙林大道138号

研究负责人通讯地址:

江苏省南京市秦淮区大明路157号

Applicant address:

138 Xianlin Dadao, Qixia District, Nanjing, Jiangsu, China

Study leader's address:

157 Daming Road, Qinhuai District, Nanjing, Jiangsu

申请注册联系人邮政编码:

Applicant postcode:

210046

研究负责人邮政编码:

Study leader's postcode:

210046

申请人所在单位:

南京中医药大学

Applicant's institution:

Nanjing University of Traditional Chinese Medicine

研究负责人所在单位:

南京市中医院

Affiliation of the Leader:

Nanjing Hospital of Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

KY2022029

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

南京市中医院伦理委员会

Name of the ethic committee:

Ethics Committee of Nanjing Hospital of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2022-02-25 00:00:00

伦理委员会联系人:

刘奇志

Contact Name of the ethic committee:

Liu Qizhi

伦理委员会联系地址:

江苏省南京市秦淮区大明路157号

Contact Address of the ethic committee:

157 Daming Road, Qinhuai District, Nanjing, Jiangsu

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 25 52276506

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

南京市中医院

Primary sponsor:

Nanjing Hospital of Chinese Medicine

研究实施负责(组长)单位地址:

江苏省南京市秦淮区大明路157号

Primary sponsor's address:

157 Daming Road, Qinhuai District, Nanjing, Jiangsu

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

江苏

市(区县):

南京

Country:

China

Province:

Jiangsu

City:

Nanjing

单位(医院):

南京市中医院

具体地址:

大明路157号

Institution
hospital:

Nanjing Hospital of Chinese Medicine

Address:

157 Daming Road

国家:

中国

省(直辖市):

江苏

市(区县):

南京

Country:

China

Province:

Jiangsu

City:

Nanjing

单位(医院):

江苏省中医院

具体地址:

汉中路155号

Institution
hospital:

Jiangsu Provincial Hospital of Traditional Chinese Medicine

Address:

155 Hanzhong Road

国家:

中国

省(直辖市):

江苏

市(区县):

南京

Country:

China

Province:

Jiangsu

City:

Nanjing

单位(医院):

南京鼓楼医院

具体地址:

中山路321号

Institution
hospital:

Nanjing Gulou Hospital

Address:

321 Zhongshan Road

国家:

中国

省(直辖市):

江苏

市(区县):

南京

Country:

China

Province:

Jiangsu

City:

Nanjing

单位(医院):

东南大学附属中大医院

具体地址:

丁家桥87号

Institution
hospital:

Zhongda Hospital Affiliated to Southeast University

Address:

87 Dingjiaqiao

经费或物资来源:

国家自然科学青年基金

Source(s) of funding:

National Natural Science Foundation of China (NSFC)

研究疾病:

炎症性肠病  

Target disease:

inflammatory bowel disease

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

横断面 

Study design:

Cross-sectional 

研究目的:

(1)解析 IBD 患者健康膳食自我决策困境类别和引致因素,总结 IBD 患者膳食营养管理内在特征和规律; (2)破解 IBD 患者健康膳食自我决策困境,构建科学预警、趋势预测和决策支持的健康膳食自我决策模型。  

Objectives of Study:

(1) To analyze the categories and contributing factors of healthy diet self-decision dilemma in IBD patients, and to summarize the internal characteristics and rules of dietary nutrition management in IBD patients; (2) To solve the dilemma of healthy diet self-decision-making in IBD patients and construct a healthy diet self-decision-making model with scientific warning, trend prediction and decision support.

药物成份或治疗方案详述:

采用纵向调查法,分别于入组时、入组后3 个月和6个月,采集受试者多维健康膳食指标,如生理病理、社会经济、认知心理、外部环境和膳食行为特征。 

Description for medicine or protocol of treatment in detail:

A longitudinal survey was conducted to collect multidimensional healthy dietary indicators, such as physiological and pathological characteristics, social economy, cognitive psychology, external environment and dietary behavior characteristics, at the time of enrollment, 3 months and 6 months after enrollment. 

纳入标准:

Inclusion criteria

排除标准:

1. 认知障碍、语言沟通障碍等影响交流者; 2. 正在参加,或一年内参加其他临床研究或心理治疗的患者; 3. 具有严重的原发性心、肝、肺、肾、血液或影响其生存的严重疾病者; 4. 妊娠或正准备妊娠的妇女,哺乳期妇女; 5. 入组前4周内接受过激素治疗; 6. 严重营养不良,素食主义、严重偏食或因宗教信仰等有明显特殊饮食需求的患者。

Exclusion criteria:

1. People with cognitive disorders and language communication disorders; 2. Patients who are participating in, or within one year have participated in, other clinical studies or psychotherapy; 3. Patients with severe primary heart, liver, lung, kidney, blood or other serious diseases affecting their survival; 4. Women who are pregnant or trying to become pregnant, breast-feeding women; 5. Received hormone therapy within 4 weeks before enrollment; 6. Patients with severe malnutrition, vegetarianism, severe partial eating or obvious special dietary needs due to religious beliefs.

研究实施时间:

Study execute time:

From 2021-11-01 00:00:00 To 2025-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-11-01 00:00:00 To 2025-12-31 00:00:00

干预措施:

Interventions:

组别:

1组

样本量:

400

Group:

Group 1

Sample size:

干预措施:

干预措施代码:

Intervention:

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

江苏 

市(区县):

南京 

Country:

China

Province:

Jiangsu

City:

Nanjing

单位(医院):

南京市中医院 

单位级别:

三甲 

Institution
hospital:

Nanjing Hospital of Chinese Medicine

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

江苏 

市(区县):

南京 

Country:

China

Province:

Jiangsu

City:

Nanjing

单位(医院):

江苏省中医院 

单位级别:

三甲 

Institution
hospital:

Jiangsu Provincial Hospital of Traditional Chinese Medicine

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

江苏 

市(区县):

南京 

Country:

China

Province:

Jiangsu

City:

单位(医院):

南京鼓楼医院 

单位级别:

三级甲等医院 

Institution
hospital:

Nanjing Gulou Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

江苏 

市(区县):

南京 

Country:

China

Province:

Jiangsu

City:

Nanjing

单位(医院):

东南大学附属中大医院 

单位级别:

三甲 

Institution
hospital:

Zhongda Hospital Affiliated to Southeast University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

饮食质量(中国膳食平衡指数DBI-16)

指标类型:

主要指标

Outcome:

Dietary Quality (Chinese Dietary Balance Index DBI-16)

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

体质指数

指标类型:

主要指标

Outcome:

Body Mass Index

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

饮食管理依从性

指标类型:

主要指标

Outcome:

Dietary management compliance

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

粪钙卫蛋白

指标类型:

次要指标

Outcome:

Fecal calprotectin

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

疾病活动度

指标类型:

次要指标

Outcome:

disease activity

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

自我效能感

指标类型:

次要指标

Outcome:

self-efficacy

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心理弹性

指标类型:

次要指标

Outcome:

mental elasticity

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

生活质量

指标类型:

次要指标

Outcome:

Quality of life

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

患者满意度

指标类型:

附加指标

Outcome:

Satisfaction of patients

Type:

Additional indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

粪便

组织:

Sample Name:

Faeces

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

No

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

No

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

https://app.mockplus.cn/app/share-954f9f8484589376f3340fcbcf968a12share-Ys7V-IvVpFm/design

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

https://app.mockplus.cn/app/share-954f9f8484589376f3340fcbcf968a12share-Ys7V-IvVpFm/design

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

电子采集 https://app.mockplus.cn/app/share-954f9f8484589376f3340fcbcf968a12share-Ys7V-IvVpFm/design

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Electronic collection:https://app.mockplus.cn/app/share-954f9f8484589376f3340fcbcf968a12share-Ys7V-IvVpFm/design

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2022-10-24 12:59:00